492
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Prevalence of Urolithiasis by Ultrasonography Among Patients with Gout: A Cross-Sectional Study from the UP-Philippine General Hospital

ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 423-431 | Published online: 25 Sep 2020

References

  • Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16:380–390. doi:10.1038/s41584-020-0441-132541923
  • Dans LF, Salido EO, Penserga EG, Navarra SV. National Nutrition and Health Survey (NNHeS): prevalence of rheumatic diseases among adult Filipinos. Phil J Int Med. 2006;44:297–303.
  • Dalbeth N, Choi HK, Joosten LAB, et al. Gout. Nat Rev Dis Primers. 2019;5:69. doi:10.1038/s41572-019-0115-y31558729
  • Trifiro G, Morabito P, Cavagna L, et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study. Ann Rheum Dis. 2013;72:694–700. doi:10.1136/annrheumdis-2011-20125422736095
  • Prasad P, Krishnan E. Filipino gout: a review. Arthritis Care Res (Hoboken). 2014;66(3):337–343. doi:10.1002/acr.2211823983155
  • Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis. 2002;40(1):37–42. doi:10.1053/ajkd.2002.3391112087559
  • Kramer HJ, Choi HK, Atkinson K, Stampfer M, Curhan GC. The association between gout and nephrolithiasis in men: the Health Professionals’ Follow-Up Study. Kidney Int. 2003;64:1022–1026. doi:10.1046/j.1523-1755.2003.t01-2-00171.x12911552
  • Roughley MJ, Belcher J, Mallen CD, Roddy E. Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies. Arthritis Res Ther. 2015;17:90. doi:10.1186/s13075-015-0610-925889144
  • Li X, Meng X, Timofeeva M, et al. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ. 2017;357:j2376. doi:10.1136/bmj.j237628592419
  • Stack AG, Johnson ME, Blak B, et al. Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study. BMJ Open. 2019;9:e031550. doi:10.1136/bmjopen-2019-031550
  • Mount DB. The kidney in hyperuricemia and gout. CurrOpin Nephrol Hypertens. 2013;22:216–223. doi:10.1097/MNH.0b013e32835ddad2
  • Wiederkehr MR, Moe OW. Uric acid nephrolithiasis: a systemic metabolic disorder. Clin Rev Bone Miner Metab. 2011;9:207–217. doi:10.1007/s12018-011-9106-625045326
  • Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. Am J Med. 2012;125:679–687. doi:10.1016/j.amjmed.2011.09.03322626509
  • Alvarez-Nemegyei J, Medina-Escobedo M, Villanueva-Jorge S, Vasquez-Mellado J. Prevalence and risk factors for urolithiasis in primary gout: is a reappraisal needed? J Rheumatol. 2005;32:2189–2191.16265701
  • Shimizu T, Hori H. The prevalence of nephrolithiasis in patients with primary gout: a cross-sectional study using helical computed tomography. J Rheumatol. 2009;36:1958–1962. doi:10.3899/jrheum.08112819605673
  • Neogi T, Jansen TLT, Dalbeth N, et al. Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015;2015(74):1789–1798. doi:10.1136/annrheumdis-2015-208237
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-0000619414839
  • Fosgate GT. Practical sample size calculations for surveillance and diagnostic investigations. J Vet Diagn Invest. 2009;21:3–14. doi:10.1177/10406387090210010219139495
  • Brisbane W, Bailey MR, Sorensen MD. An overview of kidney stone imaging techniques. Nat Rev Urol. 2016;13:654–662. doi:10.1038/nrurol.2016.15427578040
  • Arya R, Antonisamy B, Kumar S. Sample size estimation in prevalence studies. Indian J Pediatr. 2012;79(11):1482–1488. doi:10.1007/s12098-012-0763-322562262
  • Brown LD, Cat TT, DasGupta A. Interval estimation for a proportion. Stat Sci. 2001;16:101–133. doi:10.1214/ss/1009213286
  • Kim HY. Statistical notes for clinical researchers: chi-squared test and Fisher’s exact test. Restor Dent Endod. 2017;42(2):152–155. doi:10.5395/rde.2017.42.2.15228503482
  • Delacre M, Lakens D, Leys C. Why psychologists should by default use Welch’s t-test method instead of Student’s t-test. Int Rev Soc Psychol. 2017;30(1):92–101. doi:10.5334/irsp.82
  • Terkeltaub R. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol. 2010;6:30–38. doi:10.1038/nrrheum.2009.23620046204
  • Thottam GE, Krasnokutsky S, Pillinger MH. Gout and metabolic syndrome: a tangled web. Curr Rheumatol Rep. 2017;19:60. doi:10.1007/s11926-017-0688-y28844079
  • Elfishawi MM, Zleik N, Kvrgic Z, et al. The rising incidence of gout and the increasing burden of comorbidities: a population-based study over 20 years. J Rheumatol. 2018;45(4):574–579. doi:10.3899/jrheum.17080629247151
  • Li-Yu J, Salido EO, Manahan SE, et al. Philippine Clinical Practice Guidelines for the Management of Gout 2008. Philippine Rheumatol Assoc. 2008.
  • Sivera F, Andres M, Carmona L, et al. Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis. 2014;73:328–335. doi:10.1136/annrheumdis-2013-20332523868909
  • Richette P, Doherty M, Pascual E, et al. Updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29–42. doi:10.1136/annrheumdis-2016-20970727457514
  • Yu KH, Chen DY, Chen JH, Chen SY, Chen SM, Cheng TT. Management of gout and hyperuricemia: multidisciplinary consensus in Taiwan. Int J Rheumatol Dis. 2018;21(4):772–787. doi:10.1111/1756-185X.13266
  • FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020;72(6):744–760. doi:10.1002/acr.2418032391934
  • Khanna D, FitzGerald JD, Khanna P, et al. 2012 American College of Rheumatology guidelines for management of Gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken). 2012;64(10):1431–1446. doi:10.1002/acr.2177223024028
  • Torralba TP, Bayani-Sioson PS. The Filipino and gout. Semin Arthritis Rheum. 1975;4(4):307–320. doi:10.1016/0049-0172(75)90015-31135632
  • Rule AD, Krambeck AE, Lieske JC. Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol. 2011;6:2069–2075. doi:10.2215/CJN.1065111021784825
  • Keddis MT, Rule AD. Nephrolithiasis and loss of kidney function. CurrOpin Nephrol Hypertens. 2013;22:390–396. doi:10.1097/MNH.0b013e32836214b9
  • Zisman AL, Evan AP, Coe FL, Worcester EM. Do kidney stone formers have a kidney disease? Kidney Int. 2015;88:1240–1249. doi:10.1038/ki.2015.25426376133
  • Dhondup T, Kittanamongkolchai W, Vaughan LE, et al. Risk of ESRD and mortality in kidney and bladder stone formers. Am J Kidney Dis. 2018;72(6):790–797. doi:10.1053/j.ajkd.2018.06.01230146423
  • Lorenz EC, Lieske JC, Vrtiska TJ, et al. Clinical characteristics of potential kidney donors with asymptomatic kidney stones. Nephrol Dial Transplant. 2011;26:2695–2700. doi:10.1093/ndt/gfq76921285126
  • Hernandez ATS, Tee KD, Penserga E, Salido EO. Renal function of patients with gout on initial visit at a rheumatology clinic. Phil J Int Med. 2016;54(1):1–6.
  • Hernandez AT, Tee K, Salido E. Clinical profile of Filipino patients with gout seen in adult rheumatology clinics in the National Capital Region, Philippines. Phil J Int Med. 2016;54(3):1–4.
  • Hoff LS, Goldenstein-Schainberg C, Fuller R. Nephrolithiasis in gout: prevalence and characteristics of Brazilian patients. Adv Rheumatol. 2020;60(1):2. doi:10.1186/s42358-019-0106-4
  • Stasi G, Ruoti EM. A critical evaluation in the delivery of the ultrasound practice: the point of view of the radiologist. Ital J Med. 2015;9(1):5. doi:10.4081/itjm.2015.502
  • Alabousi A, Patlas MN, Mellnick VM, Chernyak V, Farshait N, Katz DS. Renal colic imaging: myths, recent trends, and controversies. Can Assoc Radiol J. 2019;70(2):164–171. doi:10.1016/j.carj.2018.09.00830853305
  • Durr-e-Sabih KAN, Craig M, Worrall JA. Sonographic mimics of renal calculi. J Ultrasound Med. 2004;23(10):1361–1367. doi:10.7863/jum.2004.23.10.136115448326
  • Nery DR, Costa YB, Mussi TC, Baroni RH. Epidemiological and imaging features that can affect the detection of ureterolithiasis on ultrasound. Radiol Bras. 2018;51(5):287–292. doi:10.1590/0100-3984.2017.011330369654
  • Wong C, Teitge B, Ross M, Young P, Robertson HL, Lang E. The accuracy and prognostic value of point-of-care ultrasound for nephrolithiasis in the emergency department: a systematic review and meta-analysis. AcadEmerg Med. 2018;25(6):684–698.
  • McCarthy CJ, Baliyan V, Kordbacheh H, Sajjad Z, Sahani D, Kambadakone A. Radiology of renal stone disease. Int J Surg. 2016;36:638–646. doi:10.1016/j.ijsu.2016.10.04527816704
  • Moreno CC, Beland MD, Goldfarb S, et al. American College of Radiology (ACR) Appropriateness Criteria®: acute onset flank pain – suspicion of stone disease (Urolithiasis). 2015 Available from: https://acsearch.acr.org/docs/69362/Narrative. Accessed 630, 2020.
  • Fulgham PF, Assimos DG, Pearle MS, Preminger GM Clinical effectiveness protocols for imaging in the management of ureteral calculous disease: american Urological Association (AUA) Technology Assessment. 2012 Available from: https://www.auanet.org/guidelines/imaging-for-ureteral-calculous-disease. Accessed 630, 2020.
  • Turk C, Neisius A, Petrik A et al. European Association of Urology (EAU) Guidelines on Urolithiasis. 2017 Available from: https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Urolithiasis_2017_10-05V2.pdf. Accessed 630, 2020.
  • Mills L, Morley EJ, Soucy Z, Vilke GM, Lam SHF. Ultrasound for the diagnosis and management of suspected urolithiasis in the emergency department. J Emerg Med. 2018;54(2):215–220. doi:10.1016/j.jemermed.2017.09.02029089155
  • Smith-Bindman R, Aubin C, Bailitz J, et al. Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med. 2014;371(12):1100–1110. doi:10.1056/NEJMoa140444625229916
  • Shimizu T, Kitada H, Umeyama M, Hori H, Takasaki N. Novel evaluation of nephrolithiasis as a complication of gout: a cross-sectional study using helical computerized tomography. J Urol. 2013;189:1747–1752. doi:10.1016/j.juro.2012.11.07623159585
  • Ramos FP, Barbosa AT, Souza RB, Seragioli F, Giorgi RDN, Rosa RF. Nephrolithiasis as a complication of gout: a cross-sectional study with helical computed tomography. Ann Rheum Dis. 2018;77(Suppl2):142.1–142. doi:10.1136/annrheumdis-2018-eular.1555
  • Shimizu T, Hori H, Umeyama M, Shimizu K. Characteristics of gout patients according to the laterality of nephrolithiasis: A cross‐sectional study using helical computed tomography. Int J Rheum Dis. 2019;22(4):567–573. doi:10.1111/1756-185X.1344330485677
  • Li ZX, Jiao GL, Zhou SM, Cheng ZY, Bashir S, Zhou Y. Evaluation of the chemical composition of nephrolithiasis using dual-energy CT in Southern Chinese gout patients. BMC Nephrol. 2019;20:273. doi:10.1186/s12882-019-1441-831324154
  • Goldsmith ZG, Lipkin ME. When (and how) to surgically treat asymptomatic renal stones. Nat Rev Urol. 2012;9:315–320. doi:10.1038/nrurol.2012.4322450602
  • Dropkin BM, Moses RA, Sharma D, Pais VM Jr. The natural history of nonobstructing asymptomatic renal stones managed with active surveillance. J Urol. 2015;193(4):1265–1269. doi:10.1016/j.juro.2014.11.05625463995
  • Ludwig WW, Ziemba JB, Matlaga BR. Difference of opinion – asymptomatic lower pole stone < 1 cm: to treat or not to treat? Opinion: do not treat. Int Braz J Urol. 2016;42(2):185–187. doi:10.1590/S1677-5538.IBJU.2016.02.0427176183
  • Lin SY, Lin CL, Chang CH, et al. Comparative risk of chronic kidney diseases in patients with urolithiasis and urological interventions: a longitudinal population‑based study. Urolithiasis. 2017;45:465–472. doi:10.1007/s00240-016-0929-y27761632
  • Mitterberger M, Aigner F, Pallwein L, et al. Sonographic detection of renal and ureteral stones. Value of the twinkling sign. Int Braz J Urol. 2009;35(5):532–539. doi:10.1590/S1677-5538200900050000419860931
  • Yavuz A, Ceken K, Alimoglu E, Kabaalioglu A. The reliability of color doppler “twinkling” artifact for diagnosing millimetrical nephrolithiasis: comparison with B-Mode US and CT scanning results. J Med Ultrason. 2015;42:215–222. doi:10.1007/s10396-014-0599-8